Another research supported these findings, indicating that the specific deletion of YAP/TAZ in the liver not only resulted in a less severe inflammatory and fibrotic phenotype but also decelerated the progression of hepatic fibrosis induced by CCl4 in mice [10]. Here, TAFAZZIN is linked to Hepatic fibrosis.